Building a new paradigm for the early recognition of behavioral variant frontotemporal dementia: Late Onset Frontal Lobe Syndrome study

Am J Geriatr Psychiatry. 2014 Jul;22(7):735-40. doi: 10.1016/j.jagp.2013.02.002. Epub 2013 Jun 25.

Abstract

Objective: To describe the aims and design of the ongoing Late Onset Frontal Lobe Syndrome study (LOF study), a study on the spectrum of neurodegenerative and psychiatric etiologies causing behavioral changes in later life, and on the role of magnetic resonance imaging (MRI), [(18)F]-fluorodeoxyglucose-positron emission tomography (FDG-PET), and cerebrospinal fluid (CSF) biomarkers in predicting and identifying the different underlying pathologies with a special focus on the behavioral variant of frontotemporal dementia.

Methods: The LOF study is an observational cross-sectional and prospective follow-up study. Patients aged 45-75 years with a frontal behavioral change consisting of apathy, disinhibition, or compulsive/stereotypical behavior were included (April 2011-2013). Patients underwent a multidisciplinary assessment by a neurologist and psychiatrist and MRI, CSF, and PET measurements at inclusion and after 2 years of follow-up.

Results: The diagnostic added value of MRI, PET, and CSF results and their predictive value will be measured after 2 years of follow-up.

Conclusion: This is the first large-scale prospective follow-up study of patients with late-onset behavioral disorders.

Keywords: behavioral disorders; bvFTD; early diagnosis; psychiatry.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Amyloid beta-Peptides / cerebrospinal fluid
  • Biomarkers / cerebrospinal fluid
  • Clinical Protocols
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Early Diagnosis
  • Female
  • Fluorodeoxyglucose F18
  • Follow-Up Studies
  • Frontotemporal Dementia / cerebrospinal fluid
  • Frontotemporal Dementia / diagnosis*
  • Frontotemporal Dementia / genetics
  • Frontotemporal Dementia / psychology
  • Functional Neuroimaging
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • Prospective Studies
  • tau Proteins / cerebrospinal fluid

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • tau Proteins
  • Fluorodeoxyglucose F18